Features Introduction

• The unique formulas enable the liquid medication to remain longer in the nasal cavity and extended the time of drug release.
• The formulations enable quick local absorption for better treatment results and reduced systemic side effects.
• Synmosa's product developments follow strict guidelines. The analytical results meet the US FDA's guidance of bioequivalence for nasal spray. The analytical items include:
  • A. Single Dose Content Uniformity Through Container Life
  • B. Droplet/Particle Size Distribution
  • C. Spray Pattern
  • D. Plume Geometry
  • E. Priming and Re-priming
  • F. Analyze Drug Distribution by Cascade Impactor

The Leading brand in Nasal Spray products.